PRINCETON, N.J., May 23, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that its experts will be sharing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at the ASMS 59th Conference on Mass Spectrometry and Allied Topics in Denver, Colorado from June 5 to June 9. PharmaNet's scientists welcome you to attend their poster sessions throughout the conference.Tuesday June 7Poster 255: On-Cartridge Derivatization for the Determination of Bisphosphonates in Human UrineAuthors: Nicolas Jean, Sylvain Lachance, Nadine Boudreau, Sofi Gagnon-Carignan, Ann LevesquePoster 277: Stability issues and method development of a polar phenolic quaternary amine compound in human plasma by LC/MS/MSAuthors: Valerie Montminy, Nicolas Piquet, Sylvain Lachance, Nadine Boudreau; Ann LevesquePoster 257: Using ICP-MS Detection for Determination of Bismuth in Human Blood and Plasma SamplesAuthors: Nadia Savard, Sebastien Gagne, Francois Viel, Brigitte Pellerin, Nadine BoudreauPoster 258: High Throughput Analysis of Biological Samples Containing Trace Metals with Limited Down Time by ICP-MSAuthors: Sebastien Gagne, Francois Viel, Nadine Boudreau, Sylvain Lachance, Sofi Gagnon-Carignan, Ann LevesquePoster 267: Development and Validation of a Dried Blood Spot Assay for the Determination of Midazolam in Human Whole Blood by LC/MS/MSAuthors: Guy Havard, Marie-Claude Theberge, Nadine Boudreau, Ann LevesquePoster 273: Ultra Low Picograms Determination of a Glucocorticoid in Human PlasmaAuthors: Nadia Smith, Nicolas Jean, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 272: An Ultrasensitive LC/MS/MS Method for the Determination of Formoterol in Human Plasma at Femtogram LevelAuthors: Isabelle M. Levesque, Francois Viel, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 271: Evaluation of Hemolysis Effect during Sample Collection and Handling to Mimic Incurred Samples during LC/MS/MS Method ValidationAuthors: Sebastien Gagne, Sylvain Lachance, Nadine Boudreau, Ann LevesquePoster 268: Analyte and Internal Standard Cross Signal Contributions in Mass Spectrometric Detection and Their Impact on the Quantitation by LC/MSAuthors: Aimin Tan, Isabelle A. Levesque, Isabelle M. Levesque, Francois Viel, Nadine Boudreau, Ann LevesquePoster 269: A Novel Automated LCMSMS Method for the Simultaneous Determination of Levothyroxine (T4) and Liothyronine (T3) in Human SerumAuthors: Gilles Provencher, Francois Viel, Nadine Boudreau, Ann LevesquePoster 270: LC/MS/MS Analysis of Doxercalciferol and its Main Metabilite in Human Plasma at Low Picogram LevelAuthors: Guy Havard, Sylvain Lachance, Nadine Boudreau, Ann LevesqueWednesday June 8Poster 146: A Robust and Selective Method for Two Omega-3 Fatty Acids (Eicosapentanoic Acid and Docosahexaenoic Acid) in Several Matrix SpeciesAuthors: Guy Havard, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann Levesque, Farhad Amiri, Bruno Battistini, Tina SampalisThursday June 9Poster 469: Determination of Polypeptides and other Large Molecular Weight Molecules by LC/MS/MSAuthors: Genevieve Emond, Nadia Savard, Simon Bedard, Philippe Belanger, Nancy Lampron, Nathalie Pelletier, Marie-Josee Marcoux, Sylvain Lachance, Nadine Boudreau, Ann LevesqueAbout PharmaNet PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.
Contact: Anne-Marie Hess
Phone: (609) 951-6842
|SOURCE PharmaNet Development Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved